Speciality: Infectious diseases
Description:
A warm welcome to all the medical professionals in this interesting learning session on bridging the gap between AMR surveillance and antibiotic policy for appropriate therapy.
In this webinar, a panel discussion would take place involving Dr Subramanian Swaminathan as the primary speaker and involving other panelists to participate and discuss the important facts associated with antibiotic resistance and the policies to be adapted for introducing an appropriate therapy.
Antimicrobial surveillance is an essential pillar in fighting against antimicrobial resistance (AMR). There is a lack of understanding and practical guidance on how surveillance data should be linked to AMS activities. Moreover, it becomes much more complex in the hospital setting because of the structural heterogeneity of hospital facilities and services.
Therefore, the webinar will give you an overall guidance on bridging the gap between AMR surveillance and antibiotic policy for appropriate therapy. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions
See More Webinars @ Hidoc Webinars
1.
BMTs that are "half-matched" are effective in treating severe sickle cell disease.
2.
What Role Should Genomic Classifier Testing Play in Prostate Cancer?
3.
New study elucidates obesity's role in fueling breast cancer progression
4.
Remote monitoring can improve recovery from cancer surgery
5.
Neural networks and label-free microscopy enable accurate detection of pancreatic tumors
1.
The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond
2.
Seeing the Unseen: The Benefits of Early Stage Breast Cancer Ultrasound
3.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
4.
Understanding Histiocytosis: Symptoms, Causes, and Treatment Options
5.
Exploring the Potential of Xospata: A New Frontier in Cancer Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
2.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation